Institutional Ownership Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX). We have compiled data on the 300 institutions that hold shares in the stock, with a total of 61.3 Million shares, which have been reported (via 13F filing form) to have a value of $3.06 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
169,932
shares
|
$8.47 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.17%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
May 15, 2025 Q1 2025 |
169,000
shares
|
$8.43 Million
0.68% of portfolio
|
Q1 2025
Reduced 38.55%
|
|
|
Jupiter Asset Management LTD
|
May 09, 2025 Q1 2025 |
168,063
shares
|
$8.38 Million
0.08% of portfolio
|
Q1 2025
New holding
|
|
|
Moody Aldrich Partners LLC
|
Apr 28, 2025 Q1 2025 |
163,483
shares
|
$8.15 Million
1.86% of portfolio
|
Q1 2025
Added 142.5%
|
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
162,065
shares
|
$8.08 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.06%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
154,067
shares
|
$7.68 Million
0.0% of portfolio
|
Q1 2025
Reduced 6.14%
|
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
153,294
shares
|
$7.64 Million
0.03% of portfolio
|
Q4 2022
Reduced 0.77%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
152,771
shares
|
$7.62 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Great Lakes Advisors, LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
152,318
shares
|
$7.6 Million
0.07% of portfolio
|
Q1 2025
Added 145.88%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
151,197
shares
|
$7.54 Million
0.0% of portfolio
|
Q4 2024
Reduced 34.85%
|
|
|
Panagora Asset Management Inc
Boston, MA |
May 15, 2025 Q1 2025 |
149,908
shares
|
$7.48 Million
0.04% of portfolio
|
Q1 2025
New holding
|
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
148,107
shares
|
$7.39 Million
0.0% of portfolio
|
Q4 2023
Reduced 69.42%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
May 13, 2025 Q1 2025 |
137,504
shares
|
$6.86 Million
0.17% of portfolio
|
Q1 2025
Reduced 57.23%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
136,842
shares
|
$6.82 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.21%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
134,269
shares
|
$6.7 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
May 15, 2025 Q1 2025 |
128,654
shares
|
$6.42 Million
0.03% of portfolio
|
Q3 2024
Reduced 0.28%
|
|
|
Man Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
128,606
shares
|
$6.41 Million
0.02% of portfolio
|
Q1 2025
Reduced 18.58%
|
|
|
Citigroup Inc
|
May 12, 2025 Q1 2025 |
121,844
shares
|
$6.08 Million
0.0% of portfolio
|
Q1 2025
Added 0.68%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
121,554
shares
|
$6.06 Million
0.0% of portfolio
|
Q1 2025
Reduced 46.12%
|
|
|
Nan Fung Group Holdings LTD
Central, K3 |
May 14, 2025 Q1 2025 |
121,400
shares
|
$6.05 Million
5.66% of portfolio
|
Q1 2025
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
120,850
shares
|
$6.03 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.81%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
115,500
shares
|
$5.76 Million
0.01% of portfolio
|
Q3 2022
Reduced 9.41%
|
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
111,432
shares
|
$5.56 Million
0.0% of portfolio
|
Q1 2025
Reduced 12.07%
|
|
|
Opaleye Management Inc.
Boston, MA |
May 15, 2025 Q1 2025 |
105,000
shares
|
$5.24 Million
1.4% of portfolio
|
Q2 2024
Reduced 6.83%
|
|
|
Trexquant Investment LP
Stamford, CT |
May 14, 2025 Q1 2025 |
103,983
shares
|
$5.19 Million
0.06% of portfolio
|
Q1 2025
Added 12.07%
|